|Bid||0.00 x 17700|
|Ask||0.00 x 17000|
|Day's range||30.20 - 30.37|
|52-week range||17.30 - 39.00|
|Beta (5Y monthly)||0.53|
|PE ratio (TTM)||112.48|
|Earnings date||02 Aug 2021 - 06 Aug 2021|
|Forward dividend & yield||0.33 (1.09%)|
|Ex-dividend date||24 Mar 2021|
|1y target est||N/A|
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Luminex Corporation (NasdaqGS: LMNX) to DiaSorin S.p.A. (OTC: DSRLF). Under the terms of the proposed transaction, shareholders of Luminex will receive only $37.00 in cash for each share of Luminex that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Luminex (LMNX) to be acquired by DiaSorin for around $1.8 billion. This is likely to advance its technology and solutions' foothold outside the United States.
Luminex (LMNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.